Skip to main content
. 2022 Aug 12;12:13768. doi: 10.1038/s41598-022-17503-6

Table 2.

Characteristics of control subjects.

ID# Age years Sex BDNF ng/ml ProBDNF ng/ml IGF1 ng/ml
C1 5 F 34.74 8.70 103.39
C2 5 M 38.07 14.56 71.43
C3 5 M 40.37 13.82 106.83
C4 5 M 43.35 10.94 84.8
C5 5 M 47.36 12.37 96.39
C6 6 M 7.14 13.94 65.71
C8 6 M 43.33 13.43 157.61
C11 6 M 42.96 11.50 95.24
C12 7 M 45.47 10.65 124.53
C13 7 F 38.1 8.23 108.7
C14 7 F 42.27 17.48 123.03
C15 7 M 27.95 17.48 113.51
C16 8 M 9.38 17.01 58.53
C17 9 M 35.56 14.90 89.44
C18 9 M 35.37 15.52 85.62
C19 9 F 34.04 13.95 107.17
C20 9 M 41.17 30.56§ 127.78
C21 10 M 30.73 14.55 103.2
C22 10 M 34.63 17.32 53.63
C23 11 M 38.05 15.22 272.04
C24 11 M 26.56 19.85 47.52
C25 11 M 20.58 nd 46.63
C26 11 F 27.01 19.36 50.32
C27 11 F 21.35 16.28 230.54
C28 11 F 36.47 17.01 115.41
C29 12 M 25.1 16.53 141.43
C30 13 M 26.41 17.40 144.11
C32 14 F 43.08 11.09 100.22
C33 14 M 35.5 16.31 250.52
Mean 8.68 M = 21 33.99 15.21 115.31
SEM ± 0.54 F = 8 1.87 0.80 10.53
Median 9.00 35.53 15.06 105.11

M male, F female, BDNF brain-derived neurotrophic factor, IGF-1 insulin-like growth factor 1, §outlier detected by Grubb’s test, nd not determined.